Status:
COMPLETED
Identify Clinical Conditions That Increase Circulating DNA Levels
Lead Sponsor:
University of Florida
Conditions:
Pregnancy
Pulmonary Embolism
Eligibility:
All Genders
18-80 years
Brief Summary
The investigators are developing a test that is expected to measure the amount of radiation a patient has been exposed to after a nuclear bomb. The investigator will do this by measuring the DNA in th...
Detailed Description
The investigator will collect 8 mL (one and one half teaspoons) of blood one time only. The investigator may also collect the patient's past medical history, test results and disease treatment.
Eligibility Criteria
Inclusion
- Patients must be adults in one of the following categories:
- Pregnant
- Suffered a pulmonary embolism within the past 48 hours
- Myocardial infarction in the past 48 hours
- Diagnosed with an autoimmune disease
- Adults age 18-80
- Self-declared healthy adults
- Patients must be willing to undergo a blood draw
- Patients must provide study-specific informed consent prior to study entry
Exclusion
- 1\. Patients not meeting the above inclusion criteria
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 28 2016
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01815996
Start Date
October 1 2012
End Date
July 28 2016
Last Update
November 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shands Davis Cancer Center
Gainesville, Florida, United States, 32610